Literature DB >> 30203529

Disruption of the redox balance with either oxidative or anti-oxidative overloading as a promising target for cancer therapy.

Bagher Farhood1, Masoud Najafi2, Eniseh Salehi3, Nasser Hashemi Goradel4, Maryam Shabani Nashtaei3,5, Neda Khanlarkhani3, Keywan Mortezaee6.   

Abstract

Oxidative stress acts as a double-edged sword by being both a promoter and a suppressor of cancer. Moderate oxidative stress is beneficial for cancer cell proliferative and invasiveness features, while overexposure of the cells to oxidative insults could induce cancer cell apoptosis and reduce hypoxia along with modulating the immune system for regression of tumor. Cancer cells and cancer stem cells have highly efficient redox systems that make them resistant to oxidative insults. The redox disruptive approach is an area of current research and key for oxidative targeted cancer therapies. This disruption is applicable by using either oxidative or anti-oxidative overloading strategies, specifically on cancer cells without influencing normal cells or tissues around tumor. The activity of tumor suppressor cells within tumor microenvironment is needed to be maintained in patients receiving such approaches.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer; oxidative stress; reactive oxygen species (ROS); redox

Year:  2018        PMID: 30203529     DOI: 10.1002/jcb.27594

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  14 in total

Review 1.  Steps in metastasis: an updated review.

Authors:  Jamal Majidpoor; Keywan Mortezaee
Journal:  Med Oncol       Date:  2021-01-04       Impact factor: 3.064

Review 2.  NK and cells with NK-like activities in cancer immunotherapy-clinical perspectives.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Med Oncol       Date:  2022-06-18       Impact factor: 3.064

Review 3.  Key promoters of tumor hallmarks.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Int J Clin Oncol       Date:  2021-11-13       Impact factor: 3.402

Review 4.  Nobiletin as an inducer of programmed cell death in cancer: a review.

Authors:  Jun Huang; Zaoshang Chang; Quzhe Lu; Xuedong Chen; Masoud Najafi
Journal:  Apoptosis       Date:  2022-03-21       Impact factor: 4.677

Review 5.  Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated.

Authors:  Keywan Mortezaee; Jamal Majidpoor; Ebrahim Kharazinejad
Journal:  Med Oncol       Date:  2022-09-07       Impact factor: 3.738

Review 6.  Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Cell Oncol (Dordr)       Date:  2022-05-19       Impact factor: 7.051

Review 7.  Emerging Perspective: Role of Increased ROS and Redox Imbalance in Skin Carcinogenesis.

Authors:  Dehai Xian; Rui Lai; Jing Song; Xia Xiong; Jianqiao Zhong
Journal:  Oxid Med Cell Longev       Date:  2019-09-16       Impact factor: 6.543

Review 8.  (Im)maturity in Tumor Ecosystem.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Front Oncol       Date:  2022-01-25       Impact factor: 6.244

9.  Potential effect of EGCG on the anti-tumor efficacy of metformin in melanoma cells.

Authors:  An'an Xu; Jeehyun Lee; Yueling Zhao; Yuefei Wang; Xiaoli Li; Ping Xu
Journal:  J Zhejiang Univ Sci B       Date:  2021-07-15       Impact factor: 3.066

Review 10.  Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies.

Authors:  Stefania Pizzimenti; Simone Ribero; Marie Angele Cucci; Margherita Grattarola; Chiara Monge; Chiara Dianzani; Giuseppina Barrera; Giuliana Muzio
Journal:  Antioxidants (Basel)       Date:  2021-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.